Literature DB >> 2881523

Update on rifampin drug interactions.

A M Baciewicz, T H Self, W B Bekemeyer.   

Abstract

Rifampin, a potent inducer of the hepatic microsomal system, has been shown to cause clinically important interactions when combined with other drugs, including oral anticoagulants, oral contraceptives, digitoxin, methadone hydrochloride, sulfonylureas, and barbiturates. Additional literature on previously described interactions has been published recently on quinidine, glucocorticoids, digoxin, and theophylline. New rifampin interactions have been described for cyclosporine, ketoconazole, chloramphenicol, beta-blockers, verapamil, and phenytoin. These interactions seem to be of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881523

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  15 in total

1.  Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect.

Authors:  J M Castel; E Cappiello; D Leopaldi; R Latini
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

2.  Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Authors:  J D Colmenero; L C Fernández-Gallardo; J A Agúndez; J Sedeño; J Benítez; E Valverde
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 3.  Methadone maintenance in the treatment of opioid dependence. A current perspective.

Authors:  J E Zweben; J T Payte
Journal:  West J Med       Date:  1990-05

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs.

Authors:  G Kaltenbach; D Levêque; J D Peter; J Salmon; H Elkhaili; A Cavalier; Y Salmon; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Phenytoin interaction with rifampicin.

Authors:  F J Abajo
Journal:  BMJ       Date:  1988-10-22

Review 7.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

8.  Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Authors:  S Wanwimolruk; W Kang; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

9.  Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.

Authors:  S M Borcherding; T L Bastian; T H Self; N Abou-Shala; B W LeDuc; R L Lalonde
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

10.  Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patients.

Authors:  G P Wormser; H Horowitz; B Dworkin
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.